Hyperlipidemias Clinical Trial
Official title:
Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Injection of Analogue Glucagon-like Peptide-2 and Oral Glucose in Humans
Some of the fat (triglyceride) from the food humans eat gets stored in the bowel. This triglyceride can then be released into the blood when another meal is consumed or in response to hormones. How the gut hormone glucagon-like peptide-2 (GLP-2) and glucose release the triglyceride from the gut is not known. The research team in this study is interested in finding out how teduglutide (a degradation resistant form of GLP-2) ang glucose, given together, release stored triglyceride from the gut by evaluating how blood lipoproteins respond to teduglutide in healthy individuals.
The lipoprotein response will be performed in 15 healthy individuals recruited by newspaper advertisements. A member of the study team will explain the study in detail on visit 1, and if the individual is interested in participating, informed consent will be obtained and preliminary screening will occur. On visit 2 participants will receive a high fat liquid meal after an overnight fast. Hourly blood samples will be taken for 5 hours, followed by a subcutaneous teduglutide injection and simultaneous glucose drink. Following the injection and drink, blood samples will be taken every 15 minutes for the first hour and every 30 minutes for the subsequent 3 hours. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03793985 -
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
|
Phase 1 | |
Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Completed |
NCT04516291 -
A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
|
Phase 2 | |
Completed |
NCT04701775 -
Effect of Different Probiotic Strains in Hypercholesterolemic Patients
|
N/A | |
Completed |
NCT03632668 -
Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
|
Phase 1 | |
Completed |
NCT03534661 -
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
|
Phase 2/Phase 3 | |
Completed |
NCT03422666 -
Plasma Lipoprotein Response to Glucagon-like Peptide-2
|
Phase 2/Phase 3 | |
Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Recruiting |
NCT04560296 -
Community-based E-Health Program for Older Adults Living With Chronic Diseases
|
N/A | |
Terminated |
NCT04073134 -
The CHORAL Flow Study
|
Phase 4 | |
Recruiting |
NCT05103254 -
Bempedoic Acid Pregnancy Surveillance Program
|
||
Not yet recruiting |
NCT05015348 -
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia
|
N/A | |
Active, not recruiting |
NCT05082350 -
Nutritional Intervention With Black Garlic
|
N/A | |
Not yet recruiting |
NCT04398771 -
To Evaluate Safety and Effectiveness of RovatitanTab.
|
||
Not yet recruiting |
NCT04064281 -
The Healthy Cantonese Diet on Cardiometabolic Syndrome
|
N/A | |
Recruiting |
NCT06257641 -
Impact of the Mediterranean Diet on Patients With Psoriasis
|
N/A | |
Completed |
NCT03690778 -
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
|
Phase 1 | |
Completed |
NCT04354987 -
Compare the Pharmacokinetics and Safety of CKD-391
|
Phase 1 |